Case study. Use of OKT 3 in a pediatric transplant patient with delayed graft function.
Zarifian
A
A
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D007683:Kidney Tubular Necrosis, Acute / Q000451:nursing / Q000628:therapy*; D016853:Muromonab-CD3; D010347:Patient Care Planning; D011183:Postoperative Complications / Q000628:therapy*
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3